Agarose Bead Technologies (ABT), a leading manufacturer of high-quality agarose resins, has completed a major expansion at its facility located in Northern Spain, Burgos. The 1000 sqm addition positions ABT as one of Europe’s largest manufacturers of agarose resins, strategically advancing its ability to meet the growing global demand for agarose resins in the pharmaceutical and bioprocessing industry
 
The Burgos site now boasts two new cleanroom facilities and has increased its annual capacity to 100,000 liters of resins per year, enabling the firm to deliver larger-scale orders. More storage space will be available to accommodate large volumes of products and ensure a robust and reliable supply chain for customers.
 
The expansion comes as ABT solidifies its commitment to supporting the growing needs of biopharmaceutical companies engaged in the development of novel therapies, such as monoclonal antibodies, vaccines, and cell and gene therapies. As these therapies require advanced purification processes, the demand for high-quality agarose resins has surged, and ABT’s expanded capabilities aim to provide critical support to manufacturers worldwide.
 
“Our investment in expanding the Burgos facility is a direct response to the increasing global demand for high-quality agarose resins,” said Carolina Egea, CEO of Agarose Bead Technologies. “This enhanced capacity will enable us to meet the evolving needs of the pharmaceutical industry, improve supply chain reliability, and reinforce our role as a trusted partner in the development of life-saving therapies.”
 
Egea continued: “In line with ABT’s dedication to sustainability and environmental responsibility, the new facility incorporates energy-efficient systems and waste-reduction strategies. The company continues to prioritize compliance with rigorous industry standards, ensuring that its products meet the highest levels of purity and performance for biopharmaceutical applications.”
 
The expansion of the new facility was completed in June 2024 and is now fully operational.